EP2807162 - SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.04.2018 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 15.06.2017 | ||
Former | Grant of patent is intended Status updated on 09.02.2017 | ||
Former | Examination is in progress Status updated on 14.11.2016 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Bayer Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE | For all designated states Bayer Intellectual Property GmbH Alfred-Nobel-Strasse 10 40789 Monheim / DE | [2014/49] | Inventor(s) | 01 /
SÜßMEIER, Frank Baubergerstr. 5 80992 München / DE | 02 /
LOBELL, Mario Am Eigenbach 16 42113 Wuppertal / DE | 03 /
GRÜNEWALD, Sylvia Kirchstr. 9 10557 Berlin / DE | 04 /
HÄRTER, Michael Ernst-Ludwig-Kirchner-Str. 56 51375 Leverkusen / DE | 05 /
BUCHMANN, Bernd Erdmannstr. 44 16540 Hohen Neuendorf / DE | 06 /
TELSER, Joachim Krummacherstr. 127 42115 Wuppertal / DE | 07 /
JÖRIßEN, Hannah Borkumstrasse 31 42579 Heiligenhaus / DE | 08 /
HÉROULT, Mélanie Kopernikusstr. 24 40223 Düsseldorf / DE | 09 /
KAHNERT, Antje Paul-Ehrlich-Str. 10 42113 Wuppertal / DE | 10 /
LUSTIG, Klemens Falkenberg 159 42113 Wuppertal / DE | 11 /
LINDNER, Niels Bodelschwinghweg 4 42115 Wuppertal / DE | [2017/23] |
Former [2014/49] | 01 /
SÜßMEIER, Frank Baubergerstr. 5 80992 München / DE | ||
02 /
LOBELL, Mario Am Eigenbach 16 42113 Wuppertal / DE | |||
03 /
GRÜNEWALD, Sylvia Kirchstr. 9 10557 Berlin / DE | |||
04 /
HÄRTER, Michael Ernst-Ludwig-Kirchner-Str. 56 51375 Leverkusen / DE | |||
05 /
BUCHMANN, Bernd Erdmannstr. 44 16540 Hohen Neuendorf / DE | |||
06 /
TELSER, Joachim Krummacherstr. 127 42115 Wuppertal / DE | |||
07 /
JÖRIßEN, Hannah Borkumstrasse 31 42579 Heiligenhaus / DE | |||
08 /
HEROULT, Melanie Kopernikusstr. 24 40223 Düsseldorf / DE | |||
09 /
KAHNERT, Antje Paul-Ehrlich-Str. 10 42113 Wuppertal / DE | |||
10 /
LUSTIG, Klemens Falkenberg 159 42113 Wuppertal / DE | |||
11 /
LINDNER, Niels Bodelschwinghweg 4 42115 Wuppertal / DE | Representative(s) | BIP Patents c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 50 40789 Monheim am Rhein / DE | [N/P] |
Former [2017/23] | BIP Patents c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10 40789 Monheim am Rhein / DE | ||
Former [2014/49] | BIP Patents c/o Bayer Intellectual Property GmbH Creative Campus Monheim Alfred-Nobel-Straße 10 40789 Monheim / DE | Application number, filing date | 13700765.4 | 22.01.2013 | [2017/23] | WO2013EP51106 | Priority number, date | EP20120152515 | 25.01.2012 Original published format: EP 12152515 | [2014/49] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2013110590 | Date: | 01.08.2013 | Language: | DE | [2013/31] | Type: | A1 Application with search report | No.: | EP2807162 | Date: | 03.12.2014 | Language: | DE | The application published by WIPO in one of the EPO official languages on 01.08.2013 takes the place of the publication of the European patent application. | [2014/49] | Type: | B1 Patent specification | No.: | EP2807162 | Date: | 07.06.2017 | Language: | DE | [2017/23] | Search report(s) | International search report - published on: | EP | 01.08.2013 | Classification | IPC: | C07D487/04, A61K31/4188, A61P35/00 | [2014/49] | CPC: |
C07D487/04 (EP,CN,US);
A61K31/4188 (EP,US);
A61K31/4439 (EP,US);
A61K31/4545 (EP,US);
A61K31/496 (EP,US);
A61K31/5377 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/49] | Extension states | BA | 25.08.2014 | ME | 25.08.2014 | Title | German: | SUBSTITUIERTE PHENYLIMIDAZOPYRAZOLE UND IHRE VERWENDUNG | [2014/49] | English: | SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF | [2014/49] | French: | PHÉNYLIMIDAZOPYRAZOLES SUBSTITUÉS ET LEUR UTILISATION | [2014/49] | Entry into regional phase | 25.08.2014 | National basic fee paid | 25.08.2014 | Designation fee(s) paid | 25.08.2014 | Examination fee paid | Examination procedure | 25.08.2014 | Examination requested [2014/49] | 13.03.2015 | Amendment by applicant (claims and/or description) | 14.09.2015 | Despatch of a communication from the examining division (Time limit: M04) | 22.01.2016 | Reply to a communication from the examining division | 02.05.2016 | Despatch of a communication from the examining division (Time limit: M06) | 10.11.2016 | Reply to a communication from the examining division | 10.02.2017 | Communication of intention to grant the patent | 27.04.2017 | Receipt of the translation of the claim(s) | 28.04.2017 | Fee for grant paid | 28.04.2017 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.09.2015 | Opposition(s) | 08.03.2018 | No opposition filed within time limit [2018/20] | Fees paid | Renewal fee | 13.01.2015 | Renewal fee patent year 03 | 11.01.2016 | Renewal fee patent year 04 | 11.01.2017 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 22.01.2013 | AL | 07.06.2017 | CY | 07.06.2017 | CZ | 07.06.2017 | DK | 07.06.2017 | EE | 07.06.2017 | FI | 07.06.2017 | HR | 07.06.2017 | LT | 07.06.2017 | LV | 07.06.2017 | MC | 07.06.2017 | MK | 07.06.2017 | MT | 07.06.2017 | NL | 07.06.2017 | PL | 07.06.2017 | PT | 07.06.2017 | RO | 07.06.2017 | RS | 07.06.2017 | SE | 07.06.2017 | SI | 07.06.2017 | SK | 07.06.2017 | SM | 07.06.2017 | TR | 07.06.2017 | BG | 07.09.2017 | NO | 07.09.2017 | GR | 08.09.2017 | IS | 07.10.2017 | AT | 22.01.2018 | IE | 22.01.2018 | LU | 22.01.2018 | BE | 31.01.2018 | CH | 31.01.2018 | LI | 31.01.2018 | [2020/34] |
Former [2020/31] | HU | 22.01.2013 | |
CY | 07.06.2017 | ||
CZ | 07.06.2017 | ||
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MC | 07.06.2017 | ||
MK | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
PT | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
TR | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
AT | 22.01.2018 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2020/28] | HU | 22.01.2013 | |
CZ | 07.06.2017 | ||
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MC | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
PT | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
TR | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
AT | 22.01.2018 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2020/15] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MC | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
TR | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
AT | 22.01.2018 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2019/30] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MC | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
AT | 22.01.2018 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2019/23] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
AT | 22.01.2018 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2019/09] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
IE | 22.01.2018 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2018/52] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
CH | 31.01.2018 | ||
LI | 31.01.2018 | ||
Former [2018/50] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
LU | 22.01.2018 | ||
BE | 31.01.2018 | ||
Former [2018/47] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
LU | 22.01.2018 | ||
Former [2018/43] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
MT | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
Former [2018/25] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SI | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
Former [2018/21] | CZ | 07.06.2017 | |
DK | 07.06.2017 | ||
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
Former [2018/11] | CZ | 07.06.2017 | |
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
PL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SK | 07.06.2017 | ||
SM | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
IS | 07.10.2017 | ||
Former [2018/10] | CZ | 07.06.2017 | |
EE | 07.06.2017 | ||
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
RO | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
SK | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
Former [2018/09] | EE | 07.06.2017 | |
FI | 07.06.2017 | ||
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
Former [2017/52] | FI | 07.06.2017 | |
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
NL | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
Former [2017/50] | FI | 07.06.2017 | |
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
LV | 07.06.2017 | ||
RS | 07.06.2017 | ||
SE | 07.06.2017 | ||
BG | 07.09.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | ||
Former [2017/49] | FI | 07.06.2017 | |
HR | 07.06.2017 | ||
LT | 07.06.2017 | ||
NO | 07.09.2017 | ||
GR | 08.09.2017 | Cited in | International search | [A]WO2004056830 (PFIZER PROD INC [US], et al) [A] 1-12* page 143, line 28 - line 29; claim 10 *; | [A] - HANHUA HUANG ET AL, "Targeting the ANGPT-TIE2 pathway in malignancy", NATURE REVIEWS. CANCER, NATUR PUBLISHING GROUP, LONDON, GB, (20100801), vol. 10, no. 8, doi:10.1038/NRC2894, ISSN 1474-175X, pages 575 - 585, XP002663788 [A] 1-12 * table 1; compounds CE-245677 * DOI: http://dx.doi.org/10.1038/nrc2894 |